LncRNA PITPNA-AS1 as a Potential Diagnostic Marker and Therapeutic Target Promotes Hepatocellular Carcinoma Progression via Modulating miR-448/ROCK1 Axis - Docwire News
Doc Wire News,
This article was originally published here Front Med (Lausanne). 2021 May 12;8:668787.